Company
LEIDOS BIOMEDICAL RESEARCH INC
50 contracts still running in our index, worth $2.0 billion, across 2 industries (R&D in Physical, Engineering & Life Sciences, Facilities Support Services).
This is every contract we have indexed for this recipient in the industries we cover — not a complete record of every federal contract this company holds. We only ingest a fixed list of NAICS codes (see Industries), so work outside those codes will not appear here even if it exists.
What this tells you
Next contract up
25days
$143.6M · National Institutes of Health
Largest expiring
$143.6M
ends 2026-10-31 · National Institutes of Health
Buying offices
1
100% of value with National Institutes of Health — concentrated
Reserved work
0
none — full and open only
Every contract we hold for this recipient was competed full and open. That usually means beating them requires competing on the same footing, rather than on a set-aside where they cannot bid.
Who buys from them
- National Institutes of Health50 · $2.0B
Where their next one is on the clock
18mo
12mo
9mo
6mo
3mo
1mo
end
past
25 days out · Award or bridge phase
Either an award is imminent or the agency has run out of runway.
Do this now
If no solicitation ever appeared, expect a bridge — a short sole-source extension of the incumbent, often six to twelve months. That is not a loss, it is a second dated shot at the same requirement, and now you know the office is behind.
What closes in 25 days
If you bid and lost: request a debrief within three days of notification (FAR 15.505/15.506). It is the only way to learn why, and it starts the clock on any protest.
| Days | Expires | Value | Incumbent | Buying office | Contract |
|---|---|---|---|---|---|
25 Closing | 2026-10-31 | $143.6M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00001 |
86 Near | 2026-12-31 | $8.0M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00014 |
112 Near | 2027-01-26 | $7.8M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00019 |
113 Near | 2027-01-27 | $10.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91025F00008 |
117 Near | 2027-01-31 | $18.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00008 |
176 Out | 2027-03-31 | $8.4M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00015 |
190 Out | 2027-04-14 | $7.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91019F00131 |
206 Out | 2027-04-30 | $20.4M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00015 |
231 Out | 2027-05-25 | $56.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00026 |
261 Out | 2027-06-24 | $11.8M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91023F00005 |
293 Out | 2027-07-26 | $16.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00010 |
328 Out | 2027-08-30 | $37.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00030 |
328 Out | 2027-08-30 | $10.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91025F00013 |
329 Out | 2027-08-31 | $67.0M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91018F00071 |
331 Out | 2027-09-02 | $10.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91019F00140 |
337 Out | 2027-09-08 | $22.4M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00019 |
337 Out | 2027-09-08 | $8.0M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91024F00032 |
340 Out | 2027-09-11 | $11.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00016 |
343 Out | 2027-09-14 | $8.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00023 |
344 Out | 2027-09-15 | $19.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00001 |
353 Out | 2027-09-24 | $8.2M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | HHSN26100040 |
354 Out | 2027-09-25 | $67.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91018F00073 |
422 Out | 2027-12-02 | $19.2M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00013 |
451 Out | 2027-12-31 | $11.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91024F00030 |
575 Out | 2028-05-03 | $14.3M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00006 |
594 Out | 2028-05-22 | $16.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91019F00135 |
635 Out | 2028-07-02 | $20.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00002 |
664 Out | 2028-07-31 | $89.6M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00009 |
688 Out | 2028-08-24 | $11.3M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00014 |
707 Out | 2028-09-12 | $25.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00029 |
709 Out | 2028-09-14 | $12.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91023F00018 |
716 Out | 2028-09-21 | $56.4M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91018F00059 |
718 Out | 2028-09-23 | $9.8M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91018F00076 |
719 Out | 2028-09-24 | $97.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00025 |
719 Out | 2028-09-24 | $17.2M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00010 |
724 Out | 2028-09-29 | $163.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91019F00139 |
967 Out | 2029-05-30 | $19.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00022 |
968 Out | 2029-05-31 | $173.3M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91023F00008 |
1058 Out | 2029-08-29 | $53.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91018F00077 |
1060 Out | 2029-08-31 | $10.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91024F00029 |
1078 Out | 2029-09-18 | $24.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91019F00138 |
1078 Out | 2029-09-18 | $11.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00032 |
1089 Out | 2029-09-29 | $233.6M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00039 |
1089 Out | 2029-09-29 | $50.0M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00014 |
1350 Out | 2030-06-17 | $25.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00013 |
1393 Out | 2030-07-30 | $11.5M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91022F00005 |
1425 Out | 2030-08-31 | $45.9M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91020F00021 |
1438 Out | 2030-09-13 | $15.1M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91025F00015 |
1575 Out | 2031-01-28 | $141.7M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91021F00004 |
1750 Out | 2031-07-22 | $14.6M | LEIDOS BIOMEDICAL RESEARCH INC | National Institutes of Health | 75N91024F00021 |
Showing all 50 of 50, soonest to expire first.
Check it yourself, or be told
The board is public and stays that way. What a subscription changes is how much of it you see and when you hear about it.
Free
$0
- The board, every industry, agency and set-aside
- The 15 contracts closest to expiry per view
- A 100-row CSV to check our numbers
- Company profiles and search
- A monthly email with a sample of what is new
- Told the day something enters the window
- Every match, not a sample
- Watch a named competitor
Recompete Watch
$79/mo
The free summary is monthly and shows a sample. This is the same data without the wait or the cap — and a recompete you hear about eleven months out is a different opportunity than one you hear about at eleven weeks. Cancel any time from the receipt.
- The board, every industry, agency and set-aside
- Every contract in the window, not the first 15
- The full 5,000-row CSV export
- Company profiles and search
- Told the day something enters the window
- Every match, not a sample
- Watch a named competitor across every industry
The board stays free. This is for seeing all of it, first.